About Cullinan Therapeutics, Inc. 
Cullinan Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 40 Schemes (21.99%)
Foreign Institutions
Held by 79 Foreign Institutions (27.59%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-50 Million
Pharmaceuticals & Biotechnology
USD 778 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.92
-53.80%
1.90






